The weight-loss properties of GLP-1 drugs, including Ozempic and Wegovy, have dominated headlines. But could they also cut alcohol consumption? And what would this mean for beverage manufacturers? The ...
Individuals who take liraglutide or semaglutide for weight loss reduce their alcohol consumption by almost two-thirds in four months, new research presented at the European Congress on Obesity (ECO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results